Events

 

  • Convergence Forum | Opportunities & Challenges of Operating Globally

    June 11-13, 2009 | Newport, Rhode Island

    Steven Tregay Ph.D., President and CEO of Forma Therapeutics will be participating in the above panel discussion. Other speakers include Lawrence Best, former CFO, Boston Scientific, and Elisabet de los Pinos, PhD CEO, Aura Biosciences. The discussion will be moderated by Rich Kivel, CEO, TheraGenetics. More information

    •  

  • Xconomny Conferece | Tomorrow’s Biotech—Innovators and Innovations

    April 30, 2009 | Cambridge, ma

    FORMA President and CEO Steven Tregay Ph.D. will be participating in the above panel discussion. Other speakers include James C. Mullen, President and CEO, Biogen Idec; Walter Gilbert, General Partner, BioVentures Investors, and University Professor Emeritus, Harvard; George Church, Professor of Genetics, Director of the Center for Computational Genetics, Harvard Medical School; Thomas Hughes, President and CEO, Zafgen; Maria Rupnick, Co-Founder, Zafgen, and Instructor of Medicine, Harvard Medical School; Steven Tregay, Founder, President, and CEO, Forma Therapeutics; Peter Hecht, CEO, Ironwood Pharmaceuticals; James Collins, University Professor and Professor of Biomedical Engineering, Boston University; Michelle Dipp, Vice President and Head of the U.S. Centre of Excellence for External Drug Discovery, GlaxoSmithKline; Gilmore N. O’Neill, Senior Director, Experimental Neurology, Biogen Idec; Sam Wadsworth, Group Vice President of Translational Research, Genzyme; Eric Olson, VP of Program and Portfolio Management, Vertex Pharmaceuticals. More information

    •  

  • Bio National Venture Conference | In the Eye of the Beholder – Attracting the Right Investors and What Makes an Investor Fall in Love?

    March 30 - April 1 | Boston, MA

    FORMA President and CEO Steven Tregay Ph.D. will be participating in the above panel discussion. The panel will be moderated by Scott Sarazen, Ernst & Young. Other panelists include Brian Dixon, Ph.D., President and CEO, BioRelix, Inc.; and Heather Preston, MD, Managing Director, TPG Biotech. More information

    •  

  • The 7th Annual Congress of 2009 | Smart Drug Discovery Section

    2009 | Shanghai, China

    FORMA Therapeutics: Diversity Oriented Synthesis and other relevant technologies for Drug Discovery by Dr. Charles Johannes, Adjunct Professor & Director of Chemisty, FORMA Therapeutics. Read abstract

    •  

  • Frontiers in Structural Biology and Drug Discovery

    February 27, 2009 | Nanyang Technological University, School of Biological Sciences, Singapore

    Diversity Oriented Synthesis in Drug Discovery by Dr. Charles Johannes, Adjunct Professor & Director of Chemisty, FORMA Therapeutics. Read abstract

    •  

  • 7th Annual BioPartnering North America

    February 8-10, 2009 | Vancouver, BC, Canada

    For more information, please click here

    •  

  • The 27th Annual J.P. Morgan Healthcare Conference

    January 12-15 2009 | San Francisco, CA

    For more information, please click here

    •  

  • NITD Symposium on Tuberculosis 2008

    September 8-12, 2008 | Maputo, Mozambique

    Diversity-oriented synthesis for drug discovery by Mike Foley, Director, Chemical Biology Platform and Director of Medicinal Chemistry, Broad Institute of MIT and Harvard